Here are some of the most quotable insights from panelists and speakers at our live event.
And make sure to save the date — and save your seat — for DeviceTalks West in Santa Clara, California on Oct. 19 and 20.
Get the full story at our sister site, Medical Design & Outsourcing.
Proximie CEO Nadine Hachach-Haram [Photo courtesy of Proximie]
Medtech insiders convened at DeviceTalks Boston 2022 in May to discuss device design, innovation and trends shaping the industry now and in the years and decades ahead.Here are some of the most quotable insights from panelists and speakers at our live event.
And make sure to save the date — and save your seat — for DeviceTalks West in Santa Clara, California on Oct. 19 and 20.
Read on to hear what medtech leaders had to say at DeviceTalks Boston 2022.
Next >>
[Image courtesy of Avail Medsystems]
Much like a normal Starbucks-goer expects the coffee to taste a certain way at any location, Daniel Hawkins wants that type of experience in the operating room.Hawkins is the CEO of Avail Medsystems, a company developing telemedicine equipment that can connect surgeons, interventional specialists and medical device sales reps. Hawkins and the team at Avail have created a set of purpose-built hardware and software that’s exactly the same in every location it’s installed.
With the uniformity across all locations, Avail designed its platform to ensure what Hawkins describes as a pure user experience akin to going to different franchises offering the same product and quality. The consistency of the Avail Medsystems system is one of the things that Hawkins thinks sets it apart in a surgical telemedicine space that boomed during the COVID-19 pandemic — and is here to stay.…
The CEO of Avail Medsystems, a company developing telemedicine equipment that can connect surgeons, interventional specialists and medical device sales reps, Hawkins and the team at Avail have created a set of purpose-built hardware and software that’s exactly the same in every location it’s installed.
With the uniformity across all locations, Avail designed its platform to ensure what Hawkins describes as a pure user experience akin to going to different franchises offering the same product and quality.
“In order to collaborate in the operating rooms, the experience has to be the same every time,” Hawkins told MassDevice. “You need to be able to rely on it. Our customers are not only physicians and providers, they’re — very imp…
With all the hype around the use of data, artificial intelligence (AI) and other technologies, the operating room environment is ever-changing.
But, how does it translate to what clinicians do in practice and how will it improve?
On the “How technology is changing the OR” panel at DeviceTalks Boston, Proximie CEO Nadine Hachach-Haram posited that question, saying that the excitement around the technology must be met with the right application.
“The quality of care has improved access but how does it ultimately make sure every patient is getting the best care the first time, every time?” Hachach-Haram said. “With that in mind, value and impact was always front of mind. … We recognized that we needed to build something fit for now that fit for the future as well.”
Hachach-Haram was on the panel alongside Activ Surgical CEO Todd Usen, Stryker VP of Digital Innovation for Surgical Technologies Siddarth Satish …
Santa Clara, California-based Avail develops an audio and video telepresence platform designed to offer real-time collaboration through interactive broadcasts of live procedures from the operating room.
The company said in a news release that Magnes will report to Founder & CEO Daniel Hawkins while leading all commercial and customer-facing activities for the company.
Among Magnes’ focuses will be to work with the sales, marketing and field service leadership and teams to continue the expansion of Avail’s platform within a broad base of care settings.
“We started Avail to address a range of structural challenges that have emerged alongside the enormous changes in the healthcare and medical device industries over the last decade. These challenges directly impact access to clinic…
DeviceTalks Weekly, powered by MassDevice
In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week’s Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.
We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they’re making in developing a device to treat diabetes.
In a second interview, bioelectronic device company Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success in treating essential tremors and how the start-up is working through COVID-19.
Finally, Chris and Tom hint at an upcoming event for the DTW communit…
In this week’s DeviceTalks Weekly podcast, co-costs Tom Salemi and Chris Newmarker walk through this week’s “Newmarker’s Newsmakers,” the Top Five #medtech stories of the week with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.
We also hear from CEO Harith Rajagopalan, MD and CFO Lisa Davidson of Fractyl Laboratories, which is making great strides in developing a device to treat diabetes.
Cala Health CEO Renee Ryan returns to the podcast to give us an update on the Cala Trio’s clinical success in reducing essential tremors and how the start-up is working through COVID-19.
Finally, Chris and Tom hint at an upcoming event for the DTW community.
Subscribe today on Apple Podcasts, Spotify, and other players.
DeviceTalks by MassDevice · Can Fractyl Labs and Cala Health go where only drugs have gone before?
COVID-19 continues to dominate medical device industry news on MassDevice.
The pandemic is causing more major lawsuit settling — as well as efforts to offer more medtech to enable better management of the coronavirus.
Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five:
5. CureVac raises more than $200M in IPOCureVac (NSDQ:CVAC) — a Germany-based biotech outfit — is developing a COVID-19 vaccine with backing from the Bill and Melinda Gates Foundation. Read the full story.
4. This telemedicine system could get medtech sales reps back to ORsAvail Medsystem’s telemedicine system could prove a more efficient way for sales reps to sit in on surgeries, especially as the COVID-19 pandemic continues to hinder access to hospitals. Read the full story.
3. FDA clears ClearMask transparent surgical mas…[Image courtesy of Avail Medsystems]
Daniel Hawkins’ surprise isn’t a matter of what, but when.The successful medtech executive and former Shockwave Medical CEO fully expected medical device makers would see Avail Medsystem’s telemedicine system as a more efficient way for sales reps to sit in on surgeries.
By Hawkins’ projections, Avail’s system would eliminate much of the time sales reps take traveling from operating room to operating room by allowing them to communicate with surgeons via camera and audio connections.
But Hawkins still didn’t expect demand for the system to come this quickly because no one could have predicted a pandemic.
“We would have been where we are today in three to four years,” Hawkins said in an interview with MassDevice. “What COVID-19 did was speed it all up … COVID put a white-hot spotlight on a problem that was already there.”
Avail’s solution is …